Riphah International University

riphah.edu.pk

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

2,075

Active

485

Phase 3

0

Total enrollment

109,828

Pipeline matrix

Showing 7 of 7 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Intralesional Acyclovir1
Intralesional Vitamin D31
Metformin1
Antidepressant1
Moderate-Intensity continuous training1
Thalidomide1
Hydroxy Urea1

Next readouts

  • 2024-12-30
  • 2026-05-20
  • 2027-06-11
  • 2027-06-19

Top conditions

  • Stroke138
  • Sports Physical Therapy99
  • Cerebral Palsy67
  • Neck Pain65
  • Low Back Pain60
  • Knee Osteoarthritis58
  • Down Syndrome38
  • Adhesive Capsulitis29

Frequently asked questions about Riphah International University

How many clinical trials does Riphah International University have on ClinicalTrials.gov?
Riphah International University is listed as the lead sponsor on 2,075 clinical trials in ClinicalTrials.gov, 485 of which are currently active (recruiting, enrolling, or ongoing).
How many of Riphah International University's trials are in Phase 3?
0 of Riphah International University's trials are in Phase 3, spread across 7 active drug programs.
What therapeutic areas does Riphah International University focus on?
Riphah International University's most-studied conditions on ClinicalTrials.gov are Stroke, Sports Physical Therapy, Cerebral Palsy, Neck Pain, Low Back Pain.
When are Riphah International University's next clinical trial readouts?
Riphah International University has 4 upcoming primary-completion readouts tracked here; the soonest is “Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients”, expected around 2024-12-30.